Japanese regulation and approval process for medical artificial intelligence (AI) as software as a medical device (SaMD): Current status and emerging challenges
Global Health & Medicine · 30.06.2026 · 8 (3) · 140-147
DOI: 10.35772/ghm.2026.01052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Global Health & Medicine, erschienen am 30.06.2026. Verfasst von Sara Takahashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Device Evaluation Division, Pharmaceutical Safety Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Device Evaluation Division, Pharmaceutical Safety Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan.
Zitieren
APA
Takahashi, S., Makino, T., Mizutani, R., Hirano, T., & Nomura, Y. (2026). Japanese regulation and approval process for medical artificial intelligence (AI) as software as a medical device (SaMD): Current status and emerging challenges. Global Health & Medicine, 8(3), 140-147. https://doi.org/10.35772/ghm.2026.01052
Vancouver
Takahashi S, Makino T, Mizutani R, Hirano T, Nomura Y. Japanese regulation and approval process for medical artificial intelligence (AI) as software as a medical device (SaMD): Current status and emerging challenges. Global Health & Medicine. 2026;8(3):140-147. doi:10.35772/ghm.2026.01052
BibTeX
@article{Takahashi2026,
author = {Takahashi, Sara and Makino, Tomohiko and Mizutani, Reiko and Hirano, Takanori and Nomura, Yumiko},
title = {Japanese regulation and approval process for medical artificial intelligence (AI) as software as a medical device (SaMD): Current status and emerging challenges},
journal = {Global Health & Medicine},
year = {2026},
volume = {8},
number = {3},
pages = {140--147},
doi = {10.35772/ghm.2026.01052}
}
EUVIMED